ETCLC | End Stage Renal Disease Treatment Choices Learning Collaborative
Company

ETCLC | End Stage Renal Disease Treatment Choices Learning Collaborative

Health And Human Services Baltimore, United States 751 employees
Employees
751

ETCLC | End Stage Renal Disease Treatment Choices Learning Collaborative Overview

Headquarters
Baltimore, United States
Website
www.etclc.org
Industry
Health And Human Services
Employees
751
Founded
2021
NAICS
Administration of Human Resource Programs
Administration of Veterans' Affairs

About ETCLC | End Stage Renal Disease Treatment Choices Learning Collaborative

The ETCLC brings transplant centers, Organ Procurement Organizations (OPOs), donor hospitals, patients, and donor families together to reduce the disparity in performance among OPOs and transplant centers with the goal of increasing kidney recoveries by OPOs and utilization of kidneys by transplant centers. Together, ETCLC members are guided by a national network of quality improvement coaches who lead QI Teams to identify best and promising practices that drive recovery and utilization performance and spread these practices throughout the kidney transplant community using the Kidney Donation and Utilization Change Package. Over a 5-year period, the End Stage Renal Disease Treatment Choices Learning Collaborative intends to achieve the following national aims: AIM 1. Increase the number of deceased donor kidneys transplanted by 28%. AIM 2a. Decrease the current national discard rate of all procured kidneys with a KDPI >= 60 by 20%. AIM 2b. Decrease the current national discard rate of all procured kidneys with a KDPI < 60 by 4%. AIM 3. Increase the utilization of high KDPI kidneys recovered (KDPI>=60) by 28%. For more information, visit etclc.org and learn more about "The Kidney Donation & Kidney Transplant Change Packages".

Compare Similar Companies to ETCLC | End Stage Renal Disease Treatment Choices Learning Collaborative